Landrigan v. Celotex Corp.

605 A.2d 1079, 127 N.J. 404, 1992 N.J. LEXIS 364
CourtSupreme Court of New Jersey
DecidedMay 6, 1992
StatusPublished
Cited by182 cases

This text of 605 A.2d 1079 (Landrigan v. Celotex Corp.) is published on Counsel Stack Legal Research, covering Supreme Court of New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Landrigan v. Celotex Corp., 605 A.2d 1079, 127 N.J. 404, 1992 N.J. LEXIS 364 (N.J. 1992).

Opinion

The opinion of the Court was delivered by

POLLOCK, J.

Plaintiff, Angelina Landrigan, sued defendants Owens-Coming Fiberglass Corporation and Owens Illinois, Inc. for the personal injuries and death of her husband, Thomas Landrigan, claiming that exposure to defendants’ asbestos had caused his death from colon cancer. She also sued The Celotex Corporation, against which all actions are stayed because it is in bankruptcy. Reference in this opinion to “defendants” is to Owens-Coming Fiberglass Corporation and Owens Illinois, Inc. To prove causation, plaintiff relied on the. testimony of two witnesses^ ajnedical doctor and an epidemiologist. ' The trial court rejected both experts’ conclusions. It rejected the medical doctor’s conclusion as a “net opinion,” unsubstantiated by facts or reasons. The court ruled that the epidemiologist, not being a physician, was unqualified to render an opinion that asbestos exposure caused cancer in a specific individual. The Appellate Division affirmed. 243 N.J.Super. 449, 579 A.2d 1268 (1990). We granted certification, 127 N.J. 324, 604 A.2d 599 (1990), and now reverse and remand to the Law Division.

*410 -I-

Decedent worked as a maintenance man and pipe insulator at the Bayonne Terminal Warehouse from 1956 until December 1981, when he was diagnosed as suffering from colon cancer. From 1956 until 1972, he allegedly worked with insulation containing asbestos supplied by defendants. In January 1982, he underwent surgery but the cancer spread, and he died in December 1982. The cause of his death was adenocarcinoma, “a malignant adenoma arising from a glandular organ,” Taber’s Cyclopedic Medical Dictionary 36 (15th ed. 1985), the most common type of colon cancer. Generally speaking, colorectal cancer is the second most common cancer in the United States, striking 140,000 persons and causing 60,000 deaths annually. Colonoscopy Recommended, Am. Med. News, Sept. 16,1991, at 39. In 1984, plaintiff filed this survivorship and wrongful death action, asserting that exposure to asbestos had caused decedent’s death.

On defendants’ motions, the trial court directed plaintiff to elect to try her claims under a strict liability theory predicated on defendants’ failure to warn, in which defendants would be barred from proving that they had neither known nor could have known that asbestos was dangerous (the state-of-the-art defense), see Beshada v. Johns-Manville Prods. Corp., 90 N.J. 191, 447 A.2d 539 (1982)), or under a combined strict liability and negligence theory. The court ruled that if plaintiff proceeded under the combined theory, it would not charge that knowledge of the dangers of asbestos was imputed to defendant. Plaintiff elected to proceed solely under the strict liability theory, thereby barring defendants’ state-of-the-art defense.

At the trial in 1989, plaintiff relied on two experts, Dr. Joseph Sokolowski, Jr., a physician who is board certified in both internal medicine and pulmonary medicine, and Dr. Joseph K. Wagoner, an epidemiologist and biostatistician but not a physician. Dr. Sokolowski never treated or examined decedent. He based his conclusions on a review of decedent’s history of *411 exposure to asbestos, the absence of other risk factors in decedent’s history, and on various epidemiological, animal, and in vitro studies. Stating that physicians regularly rely on epidemiological studies, Dr. Sokolowski testified that asbestos can cause colon cancer in humans. He also described the path asbestos fibers take from inhalation to the gastrointestinal tract.

Dr. Sokolowski testified that exposure to asbestos was the cause of decedent’s colon cancer. He relied on the ability of asbestos to cause colon cancer in humans, decedent’s exposure to asbestos, and the absence of other risk factors, such as a high-fat diet, excessive alcohol consumption, a family history of colon cancer, and prior bowel disease. Dr. Sokolowski testified further that decedent would not have contracted colon cancer if he had not been exposed to asbestos.

Plaintiff also offered Dr. Wagoner to testify that asbestos exposure had caused decedent’s colon cancer. After conducting a hearing pursuant to Evidence Rule 8, the trial court ruled that as an epidemiologist and not a physician, Dr. Wagoner was not qualified to testify that asbestos had caused decedent’s cancer. The court, however, permitted the witness to testify about epidemiological methods and studies linking colon cancer to asbestos exposure. It also allowed Dr. Wagoner to state his opinion that asbestos causes colon cancer in humans. Finally, Dr. Wagoner testified that a low-fiber diet is associated with an increased risk of colon cancer, and that smoking, hemorrhoids, arthritis® and moderate alcohol consumption are not so associated.

At the close of plaintiff's case, the trial court granted defendants’ motions for a directed verdict. See Rule 4:40-1. The court ruled that Dr. Sokolowski's testimony was a net opinion because it was supported only by epidemiological studies and the exclusion of other risk factors, explaining:

Epidemiological evidence can only be used to show that a defendant’s conduct increased a plaintiff’s risk of injury to some measurable extent but it cannot be used to answer the critical question did the asbestos cause Mr. Landrigan’s *412 colon cancer. Judge Deighan so stated in the case of [Thompson v. Merrell Dow Pharmaceuticals, 229 N.J.Super. 230 [551 A.2d 177] (App.Div.1988)].

The court also rejected plaintiff’s proffer concerning Dr. Wagoner’s testimony, stating:

Dr. Wagoner is not a medical doctor. He never prescribed a course of treatment for cancer patients. He conducted no human research. Dr. Wagoner teaches that if you can’t find the cause of a disease by medical observation and you can find no other cause for it, you then go to these studies that have been conducted and pick a cause from a known risk or an increased risk factor.
Again, I repeat that epidemiology cannot be used to predict an occurrence of health related events for a given specific individual. Therefore, it is this Court’s decision that the colon cancer claim of Mr. Landrigan and Mrs. Landrigan is dismissed as to all defendants.

Concerning Dr. Wagoner, the Appellate Division apparently relied on the fact that he had used only epidemiological methods:

Dr. Wagoner’s qualifications as an epidemiologist and biostatistician did not endow his opinion as to proximate cause with the expertise necessary to “assist the trier of fact to understand the evidence or determine [the] fact in issue” [quoting Evid.U. 56(2)]. As we noted earlier, epidemiology deals with the movement of different diseases within human populations. It does not address questions of specific causation in the individual case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cvetanka Neceva v. Stop and Shop 0820
New Jersey Superior Court App Division, 2025
Marcus Sanchez, Etc. v. Public Service Enterprise Group Inc.
New Jersey Superior Court App Division, 2025
Keith Salters, Etc. v. South Mountain Rehabilitation Center, LLC
New Jersey Superior Court App Division, 2025
Keith Thomas v. Ty Hyderally, Esquire
New Jersey Superior Court App Division, 2024
Edward Brueck v. Wawa, Inc.
New Jersey Superior Court App Division, 2024
Haydee Gallardo v. Walmart
New Jersey Superior Court App Division, 2024
Dcpp v. M.P. and D.S., in the Matter of the Guardianship of L.J.P.
New Jersey Superior Court App Division, 2024
Francesco Mongelli v. Rocco v. Mazza
New Jersey Superior Court App Division, 2024
Sakinah Rice, Etc. v. Gold Medal Environmental of Nj, Inc.
New Jersey Superior Court App Division, 2024
Dcpp v. E.T., in the Matter of L.T. and K.M.
New Jersey Superior Court App Division, 2024
State of New Jersey v. Suk Ban
New Jersey Superior Court App Division, 2024
James Donovan v. Mark I. Miller, M.D.
New Jersey Superior Court App Division, 2024
State of New Jersey v. Yoher Jimenez
New Jersey Superior Court App Division, 2024
Marcos De Oliveira v. Auto Sport of Newark, Corp.
New Jersey Superior Court App Division, 2024
William E. Coffey, III v. 46 4th Street, LLC
New Jersey Superior Court App Division, 2023
27 Orange Rd, LLC v. Montclair Township
New Jersey Tax Court, 2022

Cite This Page — Counsel Stack

Bluebook (online)
605 A.2d 1079, 127 N.J. 404, 1992 N.J. LEXIS 364, Counsel Stack Legal Research, https://law.counselstack.com/opinion/landrigan-v-celotex-corp-nj-1992.